Oklo Inc. (OKLO · NYSE)

OKLO · MARKET VIEW

Market view · as of Aug 10, 2026

Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-0.28
vs $-0.17 est · miss
52-wk position
8.4%
-72.2% vs 52w high · -0.9% 1mo

Price (last ~year)

Oklo shares rose 14.8% following the achievement of first criticality at its Groves Isotope Test Reactor and the report of $1.2 million in second-quarter revenue. Despite this operational milestone, the company posted a net loss of $48.5 million, or $0.28 per share, missing analyst expectations. Oklo maintains a cash balance of $1.64 billion against $3.3 million in total debt, though the company remains in a development phase with no trailing twelve-month revenue.

Valuation

Market cap
$8.42B
P/B
2.574
P/S
6540.62
EV/EBITDA
-125.77
Beta
1.201
Analyst target
$79.88

Quality & returns

Operating margin
0.0%
Profit margin
0.0%
ROE
-8.9%
ROA
-7.2%

Price movement

Last
$48.42
1-month
-0.9%
3-month
-34.2%
RSI (14)
61
vs SMA200
-33.3%
52-wk position
8.4% -72.2% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$1.2M$-73.2M$-48.5M$-73.2M
2026-03-31$0$-51.2M$-33.1M$-29.7M
2025-12-31$0$-57.1M$-41.4M$-42.4M
2025-09-30$0$-36.3M$-29.7M$-29.1M

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots